NasdaqCM:SMTIMedical Equipment
Sanara MedTech (SMTI) Is Down 23.5% After Q3 Loss and THP Exit – Has the Investment Case Shifted?
Sanara MedTech Inc. has reported its third quarter 2025 earnings, revealing sales of US$26.33 million and a net loss of US$30.41 million, and announced the discontinuation of its Tissue Health Plus (THP) operations completed in November 2025 as part of a business realignment toward its core surgical segment.
This shift not only repositions the company’s operational focus but also signals a response to deeper losses and the challenges faced by its digital health initiative.
Now, we'll explore...